Upgrade

Finvezto Toolkit

Jubilant Pharmova's Q2 consolidated profit fell 74% to about Rs 31 crore from Rs 120 crore a year earlier, while revenue rose 21%.

Results · 14 Nov 2026 · Jubilant Pharmova (JUBLPHARMA)

results
Latest quarter₹ Cr
Operating profit255
Net profit31

EBITDA fell 27% to about Rs 255 crore and the margin dropped to 10.7% from 17.8%. Generics revenue rose 64%, but the generics EBITDA margin was 7%.

Company page · Results tracker

Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630.